Clarke John K

Director at ATYR; Director at ALNY; Director at MOMENTA PHARMACEUTICALS INC, and 1 more

Sold, on record
$8.4M
Dollars the filings state
Form 4 sales
8
Latest May 21, 2021
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
5
Plan not stated
0
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. May 21, 2021Plan not stated

    ATYR

    Sold 2.3% of their holdings

    $11k2,500 shares at $4.34

    Filed May 25, 2021Form 4

  2. Sep 2, 2020Plan not stated

    ATYR

    Sold 6.2% of their holdings

    $30k7,360 shares at $4.01

    Filed Sep 3, 2020Form 4

  3. Aug 27, 2020Plan not stated

    ATYR

    Sold 6.1% of their holdings

    $32k7,640 shares at $4.15

    Filed Aug 28, 2020Form 4

  4. May 31, 2018Unusual

    ALNY

    Sold 62.8% of their holdings

    $1.5M15,000 shares at $100.31

    Filed Jun 4, 2018Form 4

  5. May 12, 2015Unusual

    MOMENTA PHARMACEUTICALS INC

    Sold 35.7% of their holdings

    $766k38,400 shares at $19.96

    Filed May 14, 2015Form 4

  6. May 21, 2014Unusual

    ALNY

    Sold 100% of their holdings

    $1.9M35,000 shares at $53.80

    Filed May 23, 2014Form 4

  7. Nov 30, 2006Plan not stated

    VISICU INC

    Sold 10.4% of their holdings

    $3.9M387,000 shares at $10.04

    Filed Dec 4, 2006Form 4

  8. Nov 16, 2006Plan not stated

    VISICU INC

    Sold 0.8% of their holdings

    $316k31,500 shares at $10.04

    Filed Nov 20, 2006Form 4

8 of 8

Every transaction

Every transaction on a Form 4 or Form 5 by Clarke John K
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
May 22, 2024May 23, 2024ATYRDirectorAwardedStock Option (right to buy)24,00024,000SEC
May 17, 2023May 19, 2023ATYRDirectorAwardedStock Option (right to buy)12,00012,000SEC
Apr 26, 2023Apr 28, 2023ATYRDirectorExercised or settledRestricted Stock Unit6,0000SEC
Apr 26, 2023Apr 28, 2023ATYRDirectorExercised options6,00019,797SEC
Apr 26, 2022Apr 28, 2022ATYRDirectorAwardedRestricted Stock Units6,0006,000SEC
May 21, 2021May 25, 2021ATYRDirectorSold2,500$4.34$11k108,083SEC
Apr 28, 2021Apr 29, 2021ATYRDirectorAwardedStock Option (right to buy)1,4281,428SEC
Sep 2, 2020Sep 3, 2020ATYRDirectorSold7,360$4.01$30k110,583SEC
Aug 27, 2020Aug 28, 2020ATYRDirectorSold7,640$4.15$32k117,943SEC
May 6, 2020May 8, 2020ATYRDirectorAwardedStock Option (right to buy)1,4281,428SEC
May 8, 2019May 10, 2019ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Jun 20, 2018Jun 22, 2018ALNYDirectorAwardedStock Option (right to buy)9,0009,000SEC
May 31, 2018Jun 4, 2018ALNYDirectorSold15,000$100.31$1.5M8,891SEC
May 31, 2018Jun 4, 2018ALNYDirectorExercised or settledStock Option (right to buy)15,0000SEC
May 31, 2018Jun 4, 2018ALNYDirectorExercised options15,000$27.28$409k23,891SEC
May 15, 2018May 17, 2018ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Jun 2, 2017Jun 6, 2017ALNYDirectorAwardedStock Option (right to buy)11,25011,250SEC
May 9, 2017May 11, 2017ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Jun 3, 2016Jun 7, 2016ALNYDirectorAwardedStock Option (right to buy)11,25011,250SEC
May 24, 2016May 26, 2016ATYRDirectorAwardedStock Option (right to buy)18,00018,000SEC
Jan 27, 2016Jan 29, 2016ATYRDirectorAwardedStock Option (right to buy)19,42819,428SEC
Jul 8, 2015Jul 10, 2015ATYRDirectorAwardedStock Option (right to buy)6,2866,286SEC
Jun 10, 2015Jun 11, 2015MOMENTA PHARMACEUTICALS INCDirectorAwardedStock Option (Right to Buy)17,750176,350SEC
Jun 1, 2015Jun 3, 2015ALNYDirectorAwardedStock Option (right to buy)11,25011,250SEC
May 12, 2015May 14, 2015ATYRDirectorConvertedSeries E Redeemable Convertible Preferred Stock14.9M0SEC
May 12, 2015May 14, 2015ATYRDirectorConverted1.9M1.8MSEC
May 12, 2015May 14, 2015MOMENTA PHARMACEUTICALS INCDirectorSold38,400$19.96$766k69,123SEC
May 12, 2015May 14, 2015MOMENTA PHARMACEUTICALS INCDirectorExercised or settledStock Option (Right to Buy)38,4000SEC
May 12, 2015May 14, 2015MOMENTA PHARMACEUTICALS INCDirectorExercised options38,400$10.44$401k107,523SEC
Jun 12, 2014Jun 13, 2014MOMENTA PHARMACEUTICALS INCDirectorAwardedStock Option (Right to Buy)17,750197,000SEC
Jun 5, 2014Jun 6, 2014ALNYDirectorAwardedStock Option (right to buy)15,00015,000SEC
May 21, 2014May 23, 2014ALNYDirectorSold35,000$53.80$1.9M0SEC
May 21, 2014May 23, 2014ALNYDirectorExercised or settledStock Option (Right to Buy)35,0000SEC
May 21, 2014May 23, 2014ALNYDirectorExercised options35,000$13.05$457k35,000SEC
Jun 12, 2013Jun 13, 2013VSTMDirectorBought23,171$9.60$222k2.3MSEC
Jun 11, 2013Jun 13, 2013MOMENTA PHARMACEUTICALS INCDirectorAwardedStock Option (Right to Buy)17,750179,250SEC
Jun 11, 2013Jun 12, 2013VSTMDirectorBought25,000$9.22$231k2.3MSEC
Jun 6, 2013Jun 10, 2013ALNYDirectorAwardedStock Option (Right to Buy)15,00015,000SEC
Jun 4, 2013Jun 6, 2013VSTMDirectorAwardedStock Option (Right to Buy)12,50012,500SEC
May 13, 2013May 15, 2013VSTMDirectorBought25,000$9.74$244k2.3MSEC
May 1, 2013May 3, 2013VSTMDirectorBought10,000$9.66$97k2.3MSEC
Apr 17, 2013Apr 19, 2013VSTMDirectorBought5,631$9.50$53k2.2MSEC
Dec 18, 2012Dec 20, 2012VSTMDirectorBought6,193$7.87$49k2.2MSEC
Jun 21, 2012Jun 25, 2012ALNYDirectorAwardedStock Option (Right to Buy)15,00015,000SEC
Jun 13, 2012Jun 15, 2012MOMENTA PHARMACEUTICALS INCDirectorAwardedStock Option (Right to Buy)17,750161,500SEC
Mar 6, 2012Mar 8, 2012VSTMDirectorAwardedStock Option (Right to Buy)12,50012,500SEC
Feb 1, 2012Feb 3, 2012VSTMDirectorBought250,000$10.00$2.5M2.2MSEC
Feb 1, 2012Feb 3, 2012VSTMDirectorConvertedSeries A Preferred Stock6.9M0SEC
Feb 1, 2012Feb 3, 2012VSTMDirectorConverted2M2MSEC
Jun 14, 2011Jun 15, 2011MOMENTA PHARMACEUTICALS INCDirectorAwardedStock Option (Right to Buy)17,750143,750SEC
Page 1

Sales and notices (8)

Form 144 notices and Form 4 sales by Clarke John K
Source
May 21, 2021May 25, 2021ATYRDirectorForm 4 sale2,500$11k2.3%Plan not statedSEC
Sep 2, 2020Sep 3, 2020ATYRDirectorForm 4 sale7,360$30k6.2%Plan not statedSEC
Aug 27, 2020Aug 28, 2020ATYRDirectorForm 4 sale7,640$32k6.1%Plan not statedSEC
May 31, 2018Jun 4, 2018ALNYDirectorForm 4 sale15,000$1.5M62.8%UnusualSEC
May 12, 2015May 14, 2015MOMENTA PHARMACEUTICALS INCDirectorForm 4 sale38,400$766k35.7%UnusualSEC
May 21, 2014May 23, 2014ALNYDirectorForm 4 sale35,000$1.9M100.0%UnusualSEC
Nov 30, 2006Dec 4, 2006VISICU INCDirector, 10% ownerForm 4 sale387,000$3.9M10.4%Plan not statedSEC
Nov 16, 2006Nov 20, 2006VISICU INCDirector, 10% ownerForm 4 sale31,500$316k0.8%Plan not statedSEC